ACGA
BSX icon

Atlanta Consulting Group Advisors’s Boston Scientific BSX Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,785
Closed -$552K – 146
2025
Q4 		$552K Buy
5,785
+3,048
+111% +$299K 0.12% 87
2025
Q3 		$267K Sell
2,737
-963
-26% -$99.7K 0.07% 117
2025
Q2 		$397K Hold
3,700
– – 0.11% 84
2025
Q1 		$373K Hold
3,700
– – 0.11% 83
2024
Q4 		$330K Sell
3,700
-57
-2% -$5.02K 0.12% 92
2024
Q3 		$315K Buy
3,757
+557
+17% +$43.9K 0.08% 170
2024
Q2 		$246K Hold
3,200
– – 0.05% 101
2024
Q1 		$219K Buy
+3,200
New +$206K 0.08% 122

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atlanta Consulting Group Advisors's BSX Position: Q1 2026 in Review

Atlanta Consulting Group Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 5,785 shares — an estimated $552K sold.

Atlanta Consulting Group Advisors first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $552K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Atlanta Consulting Group Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Atlanta Consulting Group Advisors sold 5,785 Boston Scientific shares in Q1 2026, an estimated $552K.
  • Atlanta Consulting Group Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
  • Atlanta Consulting Group Advisors's Boston Scientific position peaked at $552K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.